In light of the pivotal role of inflammation in driving hepatocellular carcinoma progression, we next sought to determine whether the anti‐cancer effect of FPHPE involves modulation of the JAK2/STAT3 pathway—a central mediator of tumor‐associated inflammation and survival. The gene discussed is JAK2; the disease is neoplasm.